Form 4 for INSM INSMED Inc
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001628280-24-026851 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-05 | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $21.09 | +55.0K | 122.5K | +81% | +$1.16M |
| D | 2024-06-05 | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $55.33 | -55.0K | 108.8K | -34% | -$3.04M |
| DM | 2024-06-05 | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $0.00 | -55.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | M | A | 41,250 | $22.76 | 163,760 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-03 | M | A | 13,750 | $16.07 | 122,510 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-03 | S | D | 55,000 | $55.33 | 108,760 | D | — | — | (F2) This is the weighted average sales price representing 55,000 shares sold at prices ranging from $54.69 to $55.65 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Derivative | Stock Option (right to buy) | 2024-06-03 | M | D | 13,750 | $0.00 | 0 | D | $16.07 · — to 2025-01-08 | 13,750 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 5 | Derivative | Stock Option (right to buy) | 2024-06-03 | M | D | 41,250 | $0.00 | 0 | D | $22.76 · — to 2025-05-21 | 41,250 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |